Last $0.0005 USD
Change Today 0.00 / 0.00%
Volume 112.7K
ANAS On Other Exchanges
As of 8:10 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

alternaturals inc (ANAS) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/25/14 - $0.01
52 Week Low
10/13/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ALTERNATURALS INC (ANAS)

Related News

No related news articles were found.

alternaturals inc (ANAS) Related Businessweek News

No Related Businessweek News Found

alternaturals inc (ANAS) Details

Alternaturals, Inc. manufactures and sells alternative healthcare products. It offers Hemp and Cannabis related products, as well as various safe and natural substitutes for prescription drugs. The company provides products in ADHD and concentration, allergy and sinus, children’s healthcare, cough, cold and flu, digestive health and nausea, eye care, first aid, foot care, pain relief, skin ailments, sleep and snoring aids, and stop smoking categories, as well as ear, nose, and throat care products. It also plans to operate a distribution company to centralize the fragmented alternative health product, and medical marijuana industries. The company was formerly known as Premier Mortgage Resources, Inc. and changed its name to Alternaturals, Inc. in May 2014. The company is based in Grandville, Michigan.

alternaturals inc (ANAS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

alternaturals inc (ANAS) Key Developments

Alternaturals, Inc. Announces Plans for Manufacturing Facility

Alternaturals, Inc. announced the intentions of establishing a company owned manufacturing facility to fulfill the expected orders that will inevitably result from their affiliate marketing program and potential business contracts with large retailers. After positive negotiations with major international affiliate marketers, Alternaturals is confident that the company will see significant growth in 2015 to warrant its own facility. As a result, the company has started planning for the development of a large-scale manufacturing facility to service the anticipated massive surge in demand.

Alternaturals, Inc. Recruits Mark Figula as New Chief Technology Officer

Alternaturals, Inc. announced that it has recruited Mark Figula as it's new Chief Technology Officer to lead an aggressive online advertising sales campaigns.

Alternaturals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2014

Alternaturals, Inc. announced unaudited consolidated earnings results for the second quarter ended June 30, 2014. For the quarter, the company reported revenues of $2,709.75, income from continuing operations of $1,736.13, net income from continuing operations before provision for income taxes of $1,736.13, net income of $1,736.13. Income per share ­ basic and diluted was $0.0000007. Net cash flow used in operations was $240.97.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANAS:US $0.00 USD 0.00

ANAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANAS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ANAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales NM Not Meaningful
Price/Book 0.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALTERNATURALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at